More recently, a number of studies have reported that PEDF expression is significantly reduced in several tumor types, including prostate adenocarcinoma [20], pancreatic adenocarcinoma [21], glioblastoma [22], ovarian carcinoma [23], and breast cancer [24]. Here, SERPINF1 is linked to neoplasm.